Genetic modification and variations in solvent increase the sensitivity of the yeast RAD54-GFP genotoxicity assay
Authors:
- P.W. HastwellPHP.W. Hastwell
- P.O. KeenanPKP.O. Keenan
- A.W. KnightAKA.W. Knight
- N. BillintonNBN. Billinton
- R.M. WalmsleyRWR.M. Walmsley
Open Access
- 28 June 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 20 (5) , 317-327
Abstract
The yeast (Saccharomyces cerevisiae) RAD54-GFP DNA repair reporter assay (GreenScreen® assay, GSA) can be used for early genotoxicity screening in drug discovery. During the initial validation of this preregulatory assay, a subset of known genotoxic compounds that did not give reproducibly clear positive GSA results was identified. Cell permeability, inherent drug resistance mechanisms, metabolic activation and compound solubility were identified as possible barriers to the detection of specific compounds. In this study three types of modification to the existing assay protocol were explored in order to address these possibilities: (i) modification of the reporter host strain by deletion of genes involved in cell wall integrity or with products functioning as efflux pumps (PDR5, ERG6, SNQ2, YOR1); (ii) expression in the host yeast of human phase I metabolic activation genes and (iii) variation in the test solvent system for compounds with poor aqueous solubility. The modifications described and the assay results presented show how the assay may be tailored to suit specific classes of test compound in a more analytical mode. Improvements in assay sensitivity were seen in the detection of some genotoxins using yeast cell wall mutants and those expressing human cytochrome P450 genes.Keywords
This publication has 35 references indexed in Scilit:
- Rad54 protein stimulates heteroduplex DNA formation in the synaptic phase of DNA strand exchange via specific interactions with the presynaptic Rad51 nucleoprotein filament11Edited by M. BelfortJournal of Molecular Biology, 2001
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- The application of fluorescence polarisation for the enhanced detection of green fluorescent protein (GFP) in the presence of cellular auto-fluorescence and other green fluorescent compoundsThe Analyst, 2000
- The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiaeMicrobiology, 1999
- Purification and reconstitution of activity of Saccharomyces cerevisiae P450 61, a sterol Δ22‐desaturaseFEBS Letters, 1995
- High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductaseCarcinogenesis, 1994
- An evaluation of the use of in vitro tubulin polymerisation, fungal and wheat assays to detect the activity of potential chemical aneugensMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Isolation of two developmentally regulated genes involved in spore wall maturation in Saccharomyces cerevisiae.Genes & Development, 1990
- High-copy-number integration into the ribosomal DNA of Saccharomyces cerevisiae: a new vector for high-level expressionGene, 1989
- Mutagenicity of cimetidine in nitrite-enriched human gastric juiceCarcinogenesis, 1980